A Phase I/II Trial of CPT-11 [irinotecan] With Carboplatin in Patients With Glioblastoma Multiforme Prior to Radiation Therapy

Trial Profile

A Phase I/II Trial of CPT-11 [irinotecan] With Carboplatin in Patients With Glioblastoma Multiforme Prior to Radiation Therapy

Completed
Phase of Trial: Phase I/II

Latest Information Update: 25 Mar 2011

At a glance

  • Drugs Irinotecan (Primary) ; Carboplatin
  • Indications Glioblastoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 16 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top